Biocon Ltd., an innovation-led global biopharmaceuticals company, announced, that its Board has approved the appointment of Peter Bains as the Group CEO, with effect from September 18th, 2023. He will be reporting directly to Biocon Group Chairperson, Kiran Mazumdar-Shaw. Bains has accordingly stepped down from his role on the Biocon Board as an Independent Director with…
Tag: Kiran Mazumdar- Shaw
Infosys appoints Govind Iyer as an Independent Director
by
•Infosys, a global leader in next-generation digital services and consulting, announced the appointment of Govind Iyer as an Independent Director of the Company, effective January 12, 2023. This appointment is based on recommendation of the Nomination and Remuneration Committee of the Infosys Board, and is for a period of five years, subject to the approval…
Biocon Biologics completes acquisition of Viatris’ Global Biosimilars Business
by
•Biocon Biologics Ltd., a subsidiary of Biocon Ltd., announced that it has successfully completed its multi-billion-dollar (USD) acquisition of the global biosimilars business of its partner Viatris Inc. Biocon Biologics and Viatris have obtained all applicable approvals from key global regulators including the U.S. Federal Trade Commission, the Competition Commission of India and the Reserve…
Biocon Foundation receives ‘Mahatma Award 2022 for Excellence in Social Good’
by
•Biocon Foundation, the CSR (corporate social responsibility) arm of the Bengaluru-headquartered Biocon Limited, has been conferred with the ‘Mahatma Award 2022 For Excellence in Social Good’. The awards were presented on the eve of the Birth Anniversary of the Father of the Nation Mahatma Gandhi in New Delhi. Mahatma Awards were founded and instituted by…
Biocon Biologics to acquire Viatris’ Biosimilars
by
•Biocon Biologics Ltd., a subsidiary of Biocon Ltd., announced that it has entered into a definitive agreement with its partner Viatris Inc. Accordingly, Biocon Biologics Ltd. (BBL) will acquire Viatris’ biosimilars business to create a unique fully integrated global biosimilars enterprise. Viatris will receive consideration of up to USD 3.335 billion, including cash up to…
SHRM India partners with Indeed to organise ‘Elevate’
by
•SHRM India, the world’s largest HR professional society is organising a virtual event- ‘ELEVATE’, powered by Indeed on 29th & 30th September 2021. Focused on providing career opportunities in the healthcare and health-tech space, the initiative plans to register 10,000 aspiring healthcare job seekers and 20 companies with access to job positions across roles and levels at some…
Biocon Biologics and Serum Institute Life Sciences Announce Strategic Alliance
by
•Biocon Biologics Limited (BBL), a subsidiary of Biocon Ltd. and Serum Institute Life Sciences Private Limited (SILS), a subsidiary of Serum Institute of India Pvt. Ltd. announced a strategic alliance. Under the terms of the agreement, BBL will offer approximately 15% stake to SILS, at a post-money valuation of ~$4.9 billion, for which it will…
Biocon ropes in Agnidipta Sarkar as Group CISO
by
•India’s biopharmaceutical company, Biocon, has appointed Agnidipta Sarkar as Group CISO. Sarkar has moved on from CMS IT services where he has served his tenure of two years as Director Cybersecurity. In this new role, Sarkar will be leading the cybersecurity and risk management domains at the biopharmaceutical company. Sarkar has 3 decades of experience…
Susheel Umesh joins Biocon Biologics as CCO – Emerging Markets
by
•Biocon Biologics Ltd., a fully integrated ‘pure play’ biosimilars company and a subsidiary of Biocon Ltd., announced that Susheel Umesh has joined Biocon Biologics as the Chief Commercial Officer – Emerging Markets (CCO-EMs) w.e.f. March 1, 2021. In this new role, Susheel will drive the company’s business in the Emerging Markets (EMs) and will also…
Biocon Biologics promotes Shreehas Tambe to Deputy CEO
by
•Biocon Biologics Ltd., a fully integrated ‘pure play’ biosimilars company and a subsidiary of Biocon Ltd., announced that Shreehas Tambe has been promoted to the position of Deputy Chief Executive Officer of Biocon Biologics Limited, effective from March 1, 2021. A Biocon veteran, Shreehas joined Biocon in 1997 and has, since then, taken on positions…
Biocon Biologics receives Rs 555 cr capital injection from Abu Dhabi-based ADQ
by
•Biocon Ltd, an innovation-led global biopharmaceuticals company, announced that the Board of its subsidiary Biocon Biologics Ltd has approved a primary equity investment by Abu Dhabi based ADQ, one of the region’s largest holding companies. As per the terms of the proposed agreement, ADQ will invest Rs 555 Crore for a 1.80% minority stake in…
India’s Biocon ranked among Top 5 Biotech Employers globally
by
•Biocon Ltd, an innovation-led global biopharmaceuticals company, announced that it has ranked among the Top 5 Global Biotech Employers for 2020 on the U.S.-based Science magazine’s annual ‘Science Careers Top 20 Employers’ list. Ranked at No. 5 among global pharma and biotech companies in 2020, Biocon has moved up steadily from No. 7 in 2018…
Sudha Murty’s tenure as Chairperson of Infosys Foundation extended until December 31, 2021
by
•Infosys Foundation, the philanthropic and CSR arm of Infosys, announced that after an outstanding career in public service, Sudha Murty will retire as the Chairperson of Infosys Foundation on December 31, 2021, marking a remarkable 25-year journey of selfless dedication to social causes. Sudha Murty was elected as the Chairperson of the Infosys Foundation since…
Bengaluru-based Univ.AI raises investment from Kiran Mazumdar-Shaw
by
•Univ.AI, the Bengaluru-based institution that offers state-of-the-art Data Science and AI education with a focus on teaching artificial intelligence and data science online, announced that it has raised funding from Biocon Executive Chairperson and Founder Kiran Mazumdar-Shaw. Financial details of the funding remain undisclosed. The startup will use the funding to expand the scope of…
Biocon head Kiran Mazumdar Shaw tests positive for coronavirus
by
•The Executive Chairperson of Biocon, Kiran Mazumdar Shaw recently through social media platform Twitter announced that she has tested positive for the novel coronavirus. In her tweet informing the people of her health, the 67-year old biotech industry veteran said, “I have added to the COVID count by testing positive. Mild symptoms n I hope…